收藏切换
Exploring risk factors and improvement strategies for quality management in non-clinical drug safety evaluation institutions based on on-site inspections
收藏切换
Ming YUAN1, Yi-fei CHEN2, *
Chinese Journal of New Drugs | 2026, 35(14) : 1472 - 1477
Less
收藏切换
Chinese Journal of New Drugs | 2026, 35(14): 1472-1477
Exploring risk factors and improvement strategies for quality management in non-clinical drug safety evaluation institutions based on on-site inspections
Full
Ming YUAN1, Yi-fei CHEN2, *
Affiliations
  • 1Center for Food and Drug Inspection of NMPA, Beijing 100076, China
  • 2Shanghai Center for Drug Evaluation and Inspection, Shanghai 201210, China
Published: 2026-07-30 doi: 10.20251/j.cnki.1003-3734.2026.14.003
Outline
收藏切换
Objective:

To develop a practical methodology for risk identification and quality improvement in the quality management system of non-clinical drug safety research institutions, i.e., Good Laboratory Practice (GLP) institutions, by identifying and analyzing the distribution of key factors in the operation and management of GLP institutions.

Methods:

Certain inspection fundings from different inspection types, including initial certification inspections, renewal certification inspections, and inspections for newly added test items, were used as analyzing items. Based on the demo data, key factors are identified and categorized, and the Pareto principle was applied to determine the main risk factors in the quality management of GLP institutions. Based on this, a risk identification model was constructed using externally identified inspection findings to enhance the level of quality management.

Conclusion:

By identifying and categorizing key factors, and utilizing findings from external inspections as the data foundation, this model serves as a tool for semi-quantitative analysis of quality management risk factors. It provides a reference framework for the digital transformation of quality management and facilitates risk management.

non-clinical drug safety evaluation institution  /  digital quality management  /  risk management  /  model pathway
袁铭, 陈一飞. 基于现场检查探究药物非临床安全性评价研究机构质量管理的风险因素和提升策略. 中国新药杂志, 2026 , 35 (14) : 1472 -1477 . DOI: 10.20251/j.cnki.1003-3734.2026.14.003
Ming YUAN, Yi-fei CHEN. Exploring risk factors and improvement strategies for quality management in non-clinical drug safety evaluation institutions based on on-site inspections[J]. Chinese Journal of New Drugs, 2026 , 35 (14) : 1472 -1477 . DOI: 10.20251/j.cnki.1003-3734.2026.14.003
Year 2026 volume 35 Issue 14
44
9
Cite this Article
BibTeX
Article Info
doi: 10.20251/j.cnki.1003-3734.2026.14.003
  • Online Date:2026-10-26
  • Published:2026-07-30
Article Data
Affiliations
History
  • Accepted:2025-10-21
Affiliations
    1Center for Food and Drug Inspection of NMPA, Beijing 100076, China
    2Shanghai Center for Drug Evaluation and Inspection, Shanghai 201210, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/10.20251/j.cnki.1003-3734.2026.14.003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT